PAD - Prescribing Advisory Database
Surrey
Prescribing Advisory Database

Ventolin Accuhaler (salbutamol DPI) : Asthma

Detail

Condition :
Asthma
Keywords :
Salbutamol inhalers, SABAs, bronchodilators, adrenoreceptor agonists, short acting beta 2 agonists, respiratory, reliver inhalers
BNF Codes :
030101 - Adrenoceptor Agonists

Committee Recommendations

Date
Committee Name
Narrative
Traffic Light Status
02 November 2022
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands integrated care system Area Prescribing Committee (APC) approve the use of Ventolin Accuhaler as a treatment option in the management of asthma & COPD.

Ventolin Accuhaler and Salbutamol Easyhaler are the locally preferred dry powder devices.

Salamol MDI is the locally preferred salbutamol MDI device and should be used with a spacer device.
It has a lower carbon footprint than the large volume MDIs such as Ventolin.

Branded prescribing of inhaler devices is recommended.

See local guidelines below

 
Green

Documents

Type
Document
Review Date
Guidelines (Local)
January 2024
Guidelines (Local)
November 2018
Guidelines (National)
Patient resource
Patient resource

Supplementary documents (CCG specific documents)

No records returned.

Drugs

Below are listed drugs that are used to treat Asthma.